Core Insights - Petco Health and Wellness reported a 2.3% year-over-year decline in net sales for Q1 2025, with comparable sales down 1.3%, but gross margin improved by 30 basis points to 38.2% [1] - Adjusted EBITDA increased by $13.8 million to $89.4 million, representing 6% of sales, indicating profitability improvements despite sales challenges [1] Sales and Margin Performance - The store count reached 1,393 after 30 net closures over the last six quarters, with gross margin improvement driven by average unit cost discipline and markdown optimization [2] - SG&A discipline resulted in over 180 basis points of expense leverage, approximately 60 basis points when excluding last year's disposition costs, reflecting operational efficiency amid weak demand [2][3] Strategic Initiatives - Petco is implementing targeted resets in pet consumables, increasing shelf capacity in dog food by over 10% to address out-of-stocks and labor inefficiencies [4] - The merchandising reset aims to enhance customer satisfaction and improve in-stock availability, directly addressing lost sales drivers [5] Cost Management and Profitability - Management emphasizes that cost containment is a permanent strategy, focusing on leveraging SG&A as sales recover rather than relying on temporary expense reductions [6][8] - The goal is to manage SG&A effectively to support operating margin expansion as sales grow, rather than solely focusing on cost-cutting [7] Future Outlook - For full-year 2025, Petco expects net sales to decline in the low single digits, with adjusted EBITDA projected between $375 million and $390 million, and 20-30 net store closures [9] - Q2 FY2025 adjusted EBITDA is anticipated to be $92 million to $94 million, reflecting an approximate 11% increase at the midpoint [9]